Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
Passaro, Antonio, Brahmer, Julie, Antonia, Scott, Mok, Tony, Peters, Solange
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof
Published in The lancet oncology (01.01.2017)
Published in The lancet oncology (01.01.2017)
Get full text
Journal Article
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Spigel, David R, Faivre-Finn, Corinne, Gray, Jhanelle E, Vicente, David, Planchard, David, Paz-Ares, Luis, Vansteenkiste, Johan F, Garassino, Marina C, Hui, Rina, Quantin, Xavier, Rimner, Andreas, Wu, Yi-Long, Özgüroğlu, Mustafa, Lee, Ki H, Kato, Terufumi, de Wit, Maike, Kurata, Takayasu, Reck, Martin, Cho, Byoung C, Senan, Suresh, Naidoo, Jarushka, Mann, Helen, Newton, Michael, Thiyagarajah, Piruntha, Antonia, Scott J
Published in Journal of clinical oncology (20.04.2022)
Published in Journal of clinical oncology (20.04.2022)
Get full text
Journal Article
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Antonia, Scott, Prof, Goldberg, Sarah B, MD, Balmanoukian, Ani, MD, Chaft, Jamie E, MD, Sanborn, Rachel E, MD, Gupta, Ashok, MD, Narwal, Rajesh, PhD, Steele, Keith, PhD, Gu, Yu, PhD, Karakunnel, Joyson J, MD, Rizvi, Naiyer A, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Baas, Paul, Scherpereel, Arnaud, Nowak, Anna K, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne S, Mansfield, Aaron S, Popat, Sanjay, Jahan, Thierry, Antonia, Scott, Oulkhouir, Youssef, Bautista, Yolanda, Cornelissen, Robin, Greillier, Laurent, Grossi, Francesco, Kowalski, Dariusz, Rodríguez-Cid, Jerónimo, Aanur, Praveen, Oukessou, Abderrahim, Baudelet, Christine, Zalcman, Gérard
Published in The Lancet (British edition) (30.01.2021)
Published in The Lancet (British edition) (30.01.2021)
Get full text
Journal Article
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Antonia, Scott J, Prof, López-Martin, José A, MD, Bendell, Johanna, MD, Ott, Patrick A, MD, Taylor, Matthew, MD, Eder, Joseph Paul, MD, Jäger, Dirk, MD, Pietanza, M Catherine, MD, Le, Dung T, MD, de Braud, Filippo, Prof, Morse, Michael A, Prof, Ascierto, Paolo A, MD, Horn, Leora, MD, Amin, Asim, MD, Pillai, Rathi N, MD, Evans, Jeffry, Prof, Chau, Ian, MD, Bono, Petri, MD, Atmaca, Akin, MD, Sharma, Padmanee, Prof, Harbison, Christopher T, PhD, Lin, Chen-Sheng, PhD, Christensen, Olaf, MD, Calvo, Emiliano, Dr
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
Gray, Jhanelle E., Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Hui, Rina, Kurata, Takayasu, Chiappori, Alberto, Lee, Ki Hyeong, Cho, Byoung Chul, Planchard, David, Paz-Ares, Luis, Faivre-Finn, Corinne, Vansteenkiste, Johan F., Spigel, David R., Wadsworth, Catherine, Taboada, Maria, Dennis, Phillip A., Özgüroğlu, Mustafa, Antonia, Scott J.
Published in Journal of thoracic oncology (01.02.2020)
Published in Journal of thoracic oncology (01.02.2020)
Get full text
Journal Article
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Hellmann, Matthew D., Callahan, Margaret K., Awad, Mark M., Calvo, Emiliano, Ascierto, Paolo A., Atmaca, Akin, Rizvi, Naiyer A., Hirsch, Fred R., Selvaggi, Giovanni, Szustakowski, Joseph D., Sasson, Ariella, Golhar, Ryan, Vitazka, Patrik, Chang, Han, Geese, William J., Antonia, Scott J.
Published in Cancer cell (14.05.2018)
Published in Cancer cell (14.05.2018)
Get full text
Journal Article
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.
Published in Journal of thoracic oncology (01.02.2019)
Published in Journal of thoracic oncology (01.02.2019)
Get full text
Journal Article
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study
Gettinger, Scott, Horn, Leora, Jackman, David, Spigel, David, Antonia, Scott, Hellmann, Matthew, Powderly, John, Heist, Rebecca, Sequist, Lecia V, Smith, David C, Leming, Philip, Geese, William J, Yoon, Dennis, Li, Ang, Brahmer, Julie
Published in Journal of clinical oncology (10.06.2018)
Published in Journal of clinical oncology (10.06.2018)
Get full text
Journal Article
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial
Faivre-Finn, Corinne, Vicente, David, Kurata, Takayasu, Planchard, David, Paz-Ares, Luis, Vansteenkiste, Johan F., Spigel, David R., Garassino, Marina C., Reck, Martin, Senan, Suresh, Naidoo, Jarushka, Rimner, Andreas, Wu, Yi-Long, Gray, Jhanelle E., Özgüroğlu, Mustafa, Lee, Ki H., Cho, Byoung C., Kato, Terufumi, de Wit, Maike, Newton, Michael, Wang, Lu, Thiyagarajah, Piruntha, Antonia, Scott J.
Published in Journal of thoracic oncology (01.05.2021)
Published in Journal of thoracic oncology (01.05.2021)
Get full text
Journal Article
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Creelan, Benjamin C, Wang, Chao, Teer, Jamie K, Toloza, Eric M, Yao, Jiqiang, Kim, Sungjune, Landin, Ana M, Mullinax, John E, Saller, James J, Saltos, Andreas N, Noyes, David R, Montoya, Leighann B, Curry, Wesley, Pilon-Thomas, Shari A, Chiappori, Alberto A, Tanvetyanon, Tawee, Kaye, Frederic J, Thompson, Zachary J, Yoder, Sean J, Fang, Bin, Koomen, John M, Sarnaik, Amod A, Chen, Dung-Tsa, Conejo-Garcia, Jose R, Haura, Eric B, Antonia, Scott J
Published in Nature medicine (01.08.2021)
Published in Nature medicine (01.08.2021)
Get full text
Journal Article
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Ready, Neal E., Ott, Patrick A., Hellmann, Matthew D., Zugazagoitia, Jon, Hann, Christine L., de Braud, Filippo, Antonia, Scott J., Ascierto, Paolo A., Moreno, Victor, Atmaca, Akin, Salvagni, Stefania, Taylor, Matthew, Amin, Asim, Camidge, D. Ross, Horn, Leora, Calvo, Emiliano, Li, Ang, Lin, Wen Hong, Callahan, Margaret K., Spigel, David R.
Published in Journal of thoracic oncology (01.03.2020)
Published in Journal of thoracic oncology (01.03.2020)
Get full text
Journal Article
A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC
Pan, Dong, Hu, Angela Y., Antonia, Scott J., Li, Chuan-Yuan
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, Julie, Reckamp, Karen L, Baas, Paul, Crinò, Lucio, Eberhardt, Wilfried E.E, Poddubskaya, Elena, Antonia, Scott, Pluzanski, Adam, Vokes, Everett E, Holgado, Esther, Waterhouse, David, Ready, Neal, Gainor, Justin, Arén Frontera, Osvaldo, Havel, Libor, Steins, Martin, Garassino, Marina C, Aerts, Joachim G, Domine, Manuel, Paz-Ares, Luis, Reck, Martin, Baudelet, Christine, Harbison, Christopher T, Lestini, Brian, Spigel, David R
Published in The New England journal of medicine (09.07.2015)
Published in The New England journal of medicine (09.07.2015)
Get full text
Journal Article
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E, Chow, Laura Q M, Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E, Czyzewicz, Grzegorz, Spigel, David R, Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie
Published in Journal of clinical oncology (01.03.2021)
Published in Journal of clinical oncology (01.03.2021)
Get full text
Journal Article